2019-02-25
Impact of Staging Percutaneous Coronary Intervention in Left Main Artery Disease
Publication
Publication
Insights From the EXCEL Trial
JACC: Cardiovascular Interventions , Volume 12 - Issue 4 p. 411- 412
Percutaneous coronary intervention (PCI) is an
acceptable alternative revascularization strategy to
coronary artery bypass grafting for selected patients
with unprotected left main coronary artery disease
(LMCAD). Concomitant coronary artery disease (CAD)
in other epicardial vessels is a frequent finding in
patients with LMCAD, and the operator may consider
several PCI sessions to optimally complete myocardial
revascularization.
Staging may also be required
to minimize radiation or contrast use, because of
procedural complications, operator/patient fatigue,
or for reimbursement reasons (1). No randomized trial
has investigated the impact of staging PCI in patients
with stable multivessel CAD; hence, limited data are
available regarding the safety and efficacy of staging
PCI procedures. [...]
| Additional Metadata | |
|---|---|
| doi.org/10.1016/j.jcin.2018.11.027, hdl.handle.net/1765/115368 | |
| JACC: Cardiovascular Interventions | |
| Organisation | Department of Cardio-Thoracic Surgery |
|
Collet, C., Modolo, R., Banning, A., Kandzari, D., Stables, R., Dressler, O., … Serruys, P. (2019). Impact of Staging Percutaneous Coronary Intervention in Left Main Artery Disease. JACC: Cardiovascular Interventions, 12(4), 411–412. doi:10.1016/j.jcin.2018.11.027 |
|